Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1973;47:1022-1031

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FEILD, B. J.
Right arrow Articles by RACKLEY, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FEILD, B. J.
Right arrow Articles by RACKLEY, C. E.

(Circulation. 1973;47:1022.)
© 1973 American Heart Association, Inc.


Left Ventricular Function and Hypertrophy in Cardiomyopathy with Depressed Ejection Fraction

BOLLING J. FEILD M.D.1; WILLIAM A. BAXLEY M.D.1; RICHARD O. RUSSELL JR. M.D.1; WILLIAM P. HOOD JR. M.D.1; JOHN H. HOLT M.D.1; JOHN T. DOWLING M.B., M.R.A.C.P.1; CHARLES E. RACKLEY M.D.1

1 From the Division of Cardiology, Department of Medicine, University of Alabama Medical Center and Veterans Administration Hospital, Birmingham, Alabama.

Left ventricular (LV) function and hypertrophy, assessed during cardiac catheterization by quantitative biplane angiocardiography, were related to postcatheterization course in 36 patients found to have cardiomyopathy with depressed ejection fraction (EF). EF ranged from 0.09 to 0.41, LV mass (M) from 99 to 317 g/m2, LV end-diastolic volume (V) from 104 to 347 ml/m2, and ratio of M/V from 0.66 to 1.63. In this study, EF was used as an index of LV function; M/V ratio was considered to represent a relative degree of LV hypertrophy. Postcatheterization survival rates (PCSR) for all patients at 12, 24, and 36 months were 68.8 ± 7.8%, 49.9 ± 9.2%, and 32.8 ± 10.2%. The 36-month PCSR was significantly higher for patients (N = 15) with EF ge 0.20 (75.1 ± 14.5%) than for those (N = 21) with EF < 0.20 (0%) (P < 0.01). The 36-month PCSR was also significantly higher for patients (N = 19) with M/V ratio ge 0.90 (53.6 ± 14.8%) than for those (N = 17) with M/V ratio < 0.90 (12.4 ± 10.4%) (P < 0.05). M/V ratio appeared to influence survival at least in part independently of EF. For patients with EF ge0.20 M/V ratio ge 0.90 was associated with a higher 36-month PCSR (100%) than was M/V ratio < 0.90 (25.0 ± 6.5%). Likewise, for patients with EF < 0.20, M/V ratio ge 0.90 was associated with a higher 24-month PCSR (65.1 ± 16.8%) than was M/V ratio < 0.90 (6.8 ± 9.1%); but at 36 months, PCSR was < 10% for both subgroups.

Patients (N = 16) with mitral regurgitation (MR) > 0.70 liters/min/m2 had a mean value for V (212.9 ± 74.1 ml/m2) significantly larger than for those (N = 20) without MR or with MR < 0.70 liters/min/m2 (168.8 ± 40.7 ml/m2) (P = 0.0278). Although this suggests that dilatation of the mitral valve annulus contributed to the development of the regurgitation, the large overlap in V values implies that additional mechanisms played a role.

This study describes quantitatively a spectrum of hemodynamic abnormalities in patients who had cardiomyopathy with depressed EF, and demonstrates that the present series of patients had a high postcatheterization mortality rate. Both EF and M/V ratio were of prognostic value and thus appear to be useful indices for classifying such patients.


Key Words: Mitral regurgitation • Ventricular mass • Myocardial disease • Ventricular volume




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
T. Z. Naqvi, R. K. Goel, J. S. Forrester, and R. J. Siegel
Myocardial contractile reserve on dobutamine echocardiography predicts late spontaneous improvement in cardiac function in patients with recent onset idiopathic dilated cardiomyopathy
J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1537 - 1544.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Chanda and R. Kuribayashi
The Batista procedure for dilated cardiomyopathy: An analysis that goes beyond ""hand waving""
J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 370 - 371.
[Full Text]


Home page
ANGIOLOGYHome page
T. Suzuki, T. Kanda, H. Nagaoka, S. Kubota, T. Iizuka, R. Nagai, I. Kobayashi, and T. Suzuki
Predictive Value of Left Ventricular Response to Exercise in Patients with Dilated Cardiomyopathy: Assessment by Radionuclide Ventriculography
Angiology, June 1, 1997; 48(6): 497 - 502.
[Abstract] [PDF]


Home page
NEJMHome page
G. W. Dec and V. Fuster
Idiopathic Dilated Cardiomyopathy
N. Engl. J. Med., December 8, 1994; 331(23): 1564 - 1575.
[Full Text]


Home page
ANGIOLOGYHome page
J. C. Missri
Non-Invasive Predictors of Short and Long-Term Survival in Dilated Cardiomyopathy
Angiology, August 1, 1984; 35(8): 494 - 499.
[Abstract] [PDF]